BioCentury
ARTICLE | Clinical News

AeroDose insulin: Began Phase II testing

December 18, 2000 8:00 AM UTC

AeroGen Inc. (AEGN), Sunnyvale, Calif. Product: AeroDose insulin Business: Metabolic Therapeutic category: Metabolism Target: Insulin receptors Description: Inhaled insulin using AEGN's AeroDose hand-...